The ubiquitin-proteasome pathway: The complexity and myriad functions of proteins death
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Proceedings of the National Academy of Sciences (PNAS), a peer reviewed journal of the National Academy of Sciences (NAS) - an authoritative source of high-impact, original research that broadly spans the biological, physical, and social sciences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STRUCTURE AND FUNCTIONS OF THE 20S AND 26S PROTEASOMES
Coux, O., Tanaka, K., & Goldberg, A. L. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.004101 · Cited by 2,487
Structure of 20S proteasome from yeast at 2.4Å resolution
Groll, M., Ditzel, L., Löwe, J., Stock, D., Bochtler, M., Bartunik, H. D., & Huber, R. (1997) · Nature · doi:10.1038/386463a0 · Cited by 2,257
The ubiquitin-proteasome proteolytic pathway
Ciechanover, A. (1994) · Cell · doi:10.1016/0092-8674(94)90396-4 · Cited by 1,791
Self-citationUBIQUITIN-DEPENDENT PROTEIN DEGRADATION
Hochstrasser, M. (1996) · Annual Review of Genetics · doi:10.1146/annurev.genet.30.1.405 · Cited by 1,692
Mahajan, R., Delphin, C., Guan, T., Gerace, L., & Melchior, F. (1997) · Cell · doi:10.1016/s0092-8674(00)81862-0 · Cited by 1,256
Varshavsky, A. (1992) · Cell · doi:10.1016/0092-8674(92)90285-k · Cited by 467
Editing of ubiquitin conjugates by an isopeptidase in the 26S proteasome
Lam, Y. A., Xu, W., DeMartino, G. N., & Cohen, R. E. (1997) · Nature · doi:10.1038/385737a0 · Cited by 455
Ma, C. P., Slaughter, C. A., & DeMartino, G. N. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50047-3 · Cited by 439
Nocker, S. V., Sadis, S., Rubin, D. M., Glickman, M., Fu, H., Coux, O., Wefes, I., Finley, D., & Vierstra, R. D. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6020 · Cited by 388
Purification of an 11 S regulator of the multicatalytic protease.
Dubiel, W., Pratt, G., Ferrell, K., & Rechsteiner, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41681-x · Cited by 378
Cited by
SUMO-1 Modification of IκBα Inhibits NF-κB Activation
Desterro, J. M. P., Rodriguez, M. S., & Hay, R. T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80133-1 · Cited by 1,038
Jiang, Y.-H., Armstrong, D., Albrecht, U., Atkins, C. M., Noebels, J. L., Eichele, G., Sweatt, J. D., & Beaudet, A. L. (1998) · Neuron · doi:10.1016/s0896-6273(00)80596-6 · Cited by 852
“…ing regulation of the cell cycle, signal transduction, anti-3 Department of Biochemistry gen processing, synaptic plasticity, and transcription4 Division of Neuroscience (Hochstrasser, 1996b; Hegde et al., 1997; Baumeister5 Department of Neurology et al., 1998; Ciechanover and Schwartz, 1998).”
BackgroundAssociation of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53
Honda, R., & Yasuda, H. (1999) · The EMBO Journal · doi:10.1093/emboj/18.1.22 · Cited by 724
Ubiquitin-like protein conjugation and the ubiquitin–proteasome system as drug targets
Bedford, L., Lowe, J., Dick, L. R., Mayer, R. J., & Brownell, J. E. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3321 · Cited by 563
“The UPS and UBL conjugation pathways have multiple essential biological roles and it is not surprising that their function, and often malfunction, are important factors in various human disease”
BackgroundBorodovsky, A., Kessler, B. M., Casagrande, R., Overkleeft, H. S., Wilkinson, K. D., & Ploegh, H. L. (2001) · The EMBO Journal · doi:10.1093/emboj/20.18.5187 · Cited by 504
Involvement of PIAS1 in the Sumoylation of Tumor Suppressor p53
Kahyo, T., Nishida, T., & Yasuda, H. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00349-5 · Cited by 452
Mendenhall, M. D., & Hodge, A. E. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.4.1191-1243.1998 · Cited by 429
20S Proteasome and Its Inhibitors: Crystallographic Knowledge for Drug Development
Borissenko, L., & Groll, M. (2007) · Chemical Reviews · doi:10.1021/cr0502504 · Cited by 407
Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
Uddin, M. S., Stachowiak, A., Mamun, A. A., Tzvetkov, N. T., Takeda, S., Atanasov, A. G., Bergantin, L. B., Abdel-Daim, M. M., & Stankiewicz, A. M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00004 · Cited by 395
The role of the ubiquitin-proteasome pathway in apoptosis
Orlowski, R. Z. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400505 · Cited by 386
A Giant Protease with Potential to Substitute for Some Functions of the Proteasome
Geier, E., Pfeifer, G., Wilm, M., Lucchiari-Hartz, M., Baumeister, W., Eichmann, K., & Niedermann, G. (1999) · Science · doi:10.1126/science.283.5404.978 · Cited by 375
Breitschopf, K., Haendeler, J., Malchow, P., Zeiher, A. M., & Dimmeler, S. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1886-1896.2000 · Cited by 321
Catalytic Activities of the 20 S Proteasome, a Multicatalytic Proteinase Complex
Orlowski, M., & Wilk, S. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.2036 · Cited by 308
Structural basis for the specificity of ubiquitin C-terminal hydrolases
Johnston, S. C., Riddle, S. M., Cohen, R. E., & Hill, C. P. (1999) · The EMBO Journal · doi:10.1093/emboj/18.14.3877 · Cited by 288
Role of the proteasome and NF-κB in streptococcal cell wall-induced polyarthritis
Palombella, V. J., Conner, E. M., Fuseler, J. W., Destree, A., Davis, J. M., Laroux, F. S., Wolf, R. E., Huang, J., Brand, S., Elliott, P. J., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15671 · Cited by 287
Degradation of Aux/IAA proteins is essential for normal auxin signalling
Worley, C. K., Zenser, N., Ramos, J., Rouse, D., Leyser, O., Theologis, A., & Callis, J. (2000) · The Plant Journal · doi:10.1046/j.1365-313x.2000.00703.x · Cited by 286
The ubiquitin-mediated proteolytic pathway: Mode of action and clinical implications
Ciechanover, A., Orian, A., & Schwartz, A. L. (2000) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(2000)77:34+<40::aid-jcb9>3.0.co;2-6 · Cited by 282
Self-citationKOGUCHI, Y., KOHNO, J., NISHIO, M., TAKAHASHI, K., OKUDA, T., OHNUKI, T., & KOMATSUBARA, S. (2000) · The Journal of Antibiotics · doi:10.7164/antibiotics.53.105 · Cited by 277
The proteasome activator 11 S REG (PA28) and Class I antigen presentation
RECHSTEINER, M., REALINI, C., & USTRELL, V. (2000) · Biochemical Journal · doi:10.1042/bj3450001 · Cited by 265
Part II: α-synuclein and its molecular pathophysiological role in neurodegenerative disease
Dev, K. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00140-0 · Cited by 263
Xu, G., Sztalryd, C., Lu, X., Tansey, J. T., Gan, J., Dorward, H., Kimmel, A. R., & Londos, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506569200 · Cited by 263
Neuronal Induction of the Immunoproteasome in Huntington's Disease
Díaz-Hernández, M., Hernández, F., Martín-Aparicio, E., Gómez-Ramos, P., Morán, M. A., Castaño, J. G., Ferrer, I., Avila, J., & Lucas, J. J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-37-11653.2003 · Cited by 252
Role and Function of the 26S Proteasome in Proliferation and Apoptosis
Naujokat, C., & Hoffmann, S. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000022226.23741.37 · Cited by 247
The NEDD8 Conjugation Pathway and Its Relevance in Cancer Biology and Therapy
Soucy, T. A., Dick, L. R., Smith, P. G., Milhollen, M. A., & Brownell, J. E. (2010) · Genes & Cancer · doi:10.1177/1947601910382898 · Cited by 225
Gross-Mesilaty, S., Reinstein, E., Bercovich, B., Tobias, K. E., Schwartz, A. L., Kahana, C., & Ciechanover, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8058 · Cited by 177
Self-citationThe spectrum of mutations in UBE3A causing Angelman syndrome
Fang, P. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.1.129 · Cited by 159
Ramachandran, K. V., & Margolis, S. S. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3389 · Cited by 151
Su, H., Fan, W., Coskun, P. E., Vesa, J., Gold, J.-A., Jiang, Y.-H., Potluri, P., Procaccio, V., Acab, A., Weiss, J. H., et al. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2009.06.079 · Cited by 80
“Ubiquitination is critical for proteasomal degradation of proteins and plays a role in numerous cellular processes including regulation of the cell cycle, signal transduction, synaptic plasticity and transcription [2,12].”
BackgroundAbdelmegeed, M. A., Moon, K.-H., Chen, C., Gonzalez, F. J., & Song, B.-J. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.07.016 · Cited by 81
“Protein ubiquitination is a vital pathway in maintaining cellular homeostasis through degradation of the improperly folded and/or damaged proteins [34,35].”
BackgroundNicotine coregulates multiple pathways involved in protein modification/degradation in rat brain
Kane, J. K., Konu, Ö., Ma, J. Z., & Li, M. D. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.09.010 · Cited by 61
“For example, ubiquitin-mediated protein degradation controls cell cycle progression, signal transduction, transcriptional regulation, receptor downregulation, and endocytosis [12,13,21].”
Protein–Protein Interaction Prediction for Targeted Protein Degradation
Orasch, O., Weber, N., Müller, M., Amanzadi, A., Gasbarri, C., & Trummer, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137033 · Cited by 17
Oral proteasome inhibitor with strong preclinical efficacy in myeloma models
Park, J., Park, E., Jung, C.-K., Kang, S.-W., Kim, B. G., Jung, Y., Kim, T. H., Lim, J.-Y., Lee, S.-E., Min, C.-K., et al. (2016) · BMC Cancer · doi:10.1186/s12885-016-2285-2 · Cited by 9
Yang, W. S., Kim, S. H., Kim, M., Shin, H., Lee, J., Sandmann, A., Park, O. K., Dissmeyer, N., & Song, H. K. (2025) · Nature Communications · doi:10.1038/s41467-025-63282-9 · Cited by 4
Metadata
- Authors
- Ciechanover, A., & Schwartz, A. L.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1998-03-17
- Volume
- 95
- Issue
- 6
- Pages
- 2727-2730
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2087092058
- Cited by
- 507
- References
- 24
- FWCI
- 8.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.